Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Cullinan Therapeutics Inc (CGEM)

180 + Investors. Track Smart Money conviction in CGEM. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +9
Streak
4Q ▲
Buyers last Q
63%

Smart Money Signals — CGEM

Based on 181 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 4 quarters in a row

last 6Q
For 4 consecutive quarters, more hedge funds added CGEM than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
181 hedge funds hold CGEM right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +27% more funds vs a year ago

fund count last 6Q
+38 new funds entered over the past year (+27% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 63% buying

119 buying70 selling
Last quarter: 119 funds were net buyers (34 opened a brand new position + 85 added to an existing one). Only 70 were sellers (45 trimmed + 25 sold completely). A clear majority buying is a strong confirmation signal.
➡️

Steady new buyers — ~34 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 27 → 30 → 38 → 34. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

43% of holders stayed for 2+ years

■ 43% conviction (2yr+) ■ 23% medium ■ 34% new
78 out of 181 hedge funds have held CGEM for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Value +42% but shares only +10% — price-driven

Value
+41%
Shares
+10%
Last quarter: the total dollar value of institutional holdings rose +42%, but actual share count only changed +10%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
📈

Growing discovery — still being found

19 → 27 → 30 → 38 → 34 new funds/Q
New funds entering each quarter: 27 → 30 → 38 → 34. A growing number of institutions are discovering CGEM each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Veteran-anchored — 52% veterans vs 31% newcomers

■ 52% veterans ■ 17% 1-2yr ■ 31% new
Entry-cohort mix of 187 holders: 97 (52%) are 2+ year veterans, 32 entered 1–2 years ago, and 58 (31%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
✅

Strong quality — 31% AUM from major funds

31% from top-100 AUM funds
43 of 180 holders rank in the top 100 by AUM, accounting for 31% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
4.3
out of 10
Moderate Exit Risk
Exit risk score 4.3/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — CGEM

In 2026 Q2, 119 hedge funds were net buyers of CGEM (34 opened a new position, 85 added to an existing one), while 70 reduced or exited (45 trimmed, 25 sold completely) — a 63% buyer ratio, indicating clear institutional accumulation. This marks 4 consecutive quarters of net institutional buying — a persistent conviction signal. 31% of total institutional value in CGEM is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +9 funds (more new holders than closures). Total institutional holders: 181.

Hedge Fund Ownership: CGEM

How many hedge funds hold CGEM — quarterly history vs. share price
Quarterly hedge fund ownership of CGEM vs. share price

Market Analysis: CGEM

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: CGEM

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Loading signal freshness…
Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

10 top-rated funds 3 high-conviction
Consensus
4.5
/ 10
breadth
×
Elite
2.6
/ 10
conviction
Hedge Fund Positioning: CGEM
180 + Investors

Track Smart Money conviction in CGEM. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 180 172 4.65%
13F Shares 72M 66M 10.34%
Total Value $1.28B $901M 41.61%
New Positions 34 38 -4
Increased Positions 83 60 +23
Closed Positions 25 18 +7
Reduced Positions 44 40 +4
Total Calls 4 3 33.33%
Total Puts 3 1 200.0%
PUT/CALL Ratio 0.75 0.33 Neutral

Statistics: CGEM

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

180 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in CGEM. Verified SEC 13F-HR filings.

QUARTER:
Top 25 CGEM holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Lynx1 Capital Management LP 32.16% 8,963,500 $163.2M
2 MPM BioImpact LLC 10.81% 9,731,341 $177.2M
3 Blue Owl Capital Holdings LP 4.22% 1,539,764 $28.0M
4 Elmind Capital, LP 3.16% 690,000 $12.6M
5 Kynam Capital Management, LP 3.13% 3,114,132 $56.7M
6 Boone Capital Management LLC 3.00% 704,442 $12.8M
7 Bvf Inc/Il 2.68% 5,750,683 $104.7M
8 Twin Focus Capital Partners, LLC 1.10% 595,489 $10.8M
9 Great Point Partners LLC 1.03% 300,000 $5.5M
10 Bleichroeder LP 0.81% 250,000 $4.6M
11 Venrock Adviser, LLC 0.76% 1,379,965 $25.1M
12 Affinity Asset Advisors, LLC 0.72% 875,760 $15.9M
13 Siren, L.L.C. 0.70% 1,893,410 $34.5M
14 Knott David M Jr 0.67% 69,182 $1.3M
15 Verdad Advisers, LP 0.51% 28,987 $528K
16 Rtw Investments, LP 0.37% 2,364,347 $43.1M
17 AlphaCentric Advisors LLC 0.32% 20,426 $372K
18 PFM Health Sciences, LP 0.30% 192,442 $3.5M
19 Boothbay Fund Management, LLC 0.26% 1,082,611 $19.7M
20 Optimize Financial INC. 0.18% 28,061 $511K
21 TCG Crossover Management, LLC 0.18% 406,786 $7.4M
22 Birchview Capital, LP 0.17% 20,000 $364K
23 Apis Capital Advisors, LLC 0.14% 80,000 $1.5M
24 Sound Capital Solutions LLC 0.12% 28,061 $511K
25 Perceptive Advisors LLC 0.12% 426,478 $7.8M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Cullinan Therapeutics Inc (CGEM)

What does the Smart Money Trend signal show for CGEM?

Buying streak — 4 quarters in a row: For 4 consecutive quarters, more hedge funds added CGEM than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for CGEM?

More buyers than sellers — 63% buying: Last quarter: 119 funds were net buyers (34 opened a brand new position + 85 added to an existing one). Only 70 were sellers (45 trimmed + 25 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for CGEM holders?

Strong quality — 31% AUM from major funds: 43 of 180 holders rank in the top 100 by AUM, accounting for 31% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held CGEM?

43% of holders stayed for 2+ years: 78 out of 181 hedge funds have held CGEM for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →